Navigation Links
ANA598 Data Presented at AASLD Highlight Positive Clinical Profile of DAA Entering Phase IIb
Date:10/30/2010

luded as well as interim SVR rates based on data available to date; and (v) the beneficial effect of ANA598 in both CC and non-CC patients based on observations in the Phase II combination study. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause Anadys' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. For example, the results of preclinical and early clinical studies may not be predictive of future results, and Anadys cannot provide any assurances that ANA598 or ANA773 will not have unforeseen safety issues, will have favorable results in future clinical trials or will receive regulatory approval. In addition, Anadys' results may be affected by competition from other biotechnology and pharmaceutical companies, its effectiveness at managing its financial resources, its ability to enter into transactions around its product candidates, its ability to successfully develop and market products, difficulties or delays in its preclinical studies or clinical trials, difficulties or delays in manufacturing its clinical trials materials, the scope and validity of patent protection for its products, regulatory developments and its ability to obtain additional funding to support its operations. Risk factors that may cause actual results to differ are more fully discussed in Anadys' SEC filings, including Anadys' Form 10-K for the year ended December 31, 2009, Form 10-Q for the quarter ended September 30, 2010 and Form 8-K filed on October 15, 2010. All forward-looking statements are qualified in their entirety by this cautionary statement. Anadys is providing this information as of this date and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

Pegasys® and Copegus® are registered trademarks of Ho
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
6. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
7. ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
8. ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
9. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
10. ANA598 Demonstrates Positive 4-Week Results at 200 mg BID
11. ANA598 Demonstrates SVR12 in 100% of First Group of HCV Patients Randomized to Stop All Treatment at Week 24
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... , June 30, 2015 Pulse ... issued a survey to Rosacea sufferers as part of their ... treatments Rosacea sufferers found effective for their Rosacea. The survey ... and comprised 47% men and 53% women. The ... survey participants did not consider or attempt to visit their ...
(Date:6/30/2015)... First Choice Wellness Care recently upgraded their ... is the only clinic in the greater ... The practice has recently expanded their services and added ... their focus in the procedure. They upgraded to the ... clearance, and superior service. "We,ve been providing ...
(Date:6/30/2015)... ALISO VIEJO, Calif. , June 30, 2015 ... from the PRISM II study showing that treatment ... statistically significant reduction in symptoms of pseudobulbar affect ... or stroke. PBA is a distressing condition characterized ... crying resulting from certain neurologic diseases or brain ...
Breaking Medicine Technology:84% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 284% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 3First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 2First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7
(Date:6/30/2015)... ... 2015 , ... According to a recent report by the U.S. Drug Enforcement ... than tripled in the same period—leading a majority of law enforcement agencies to cite ... leading Florida-based drug treatment facility, asserts that these heroin statistics point to an urgent ...
(Date:6/30/2015)... ... June 30, 2015 , ... Broadway by the Sea posted its newest ... family member testimonials. Medicare rated the care center as a five-star location based on ... to give future patients a firsthand look at the facility’s satisfied residents. , ...
(Date:6/30/2015)... ... ... From the moment a patient enters the office of Dr. Breiterman at ... and the luxury in which they are bathed. The office has always offered ... same experience, just better! , Their office is a state-of the-art facility using only ...
(Date:6/30/2015)... NJ (PRWEB) , ... June 30, 2015 , ... ... executive vice president and general manager of HRA Healthcare Research & Analytics ... N.J.-based Michael J. Hennessy Associates, Inc. (MJH) family of businesses. HRA offers quantitative ...
(Date:6/30/2015)... ... ... Independence Day weekend is more than just fireworks to celebrate America’s birthday, ... as National Hot Dog Month. Americans are expected to eat more than 150 million ... and enough to stretch from Washington D.C. to Los Angeles more than five times. ...
Breaking Medicine News(10 mins):Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 2Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 3Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 4Health News:Broadway by the Sea Video Promotes Top Quality Service 2Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 2Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 3Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 4Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 2Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 3Health News:Biggest Hot Dog Weekend of the Year to Kick Off National Hot Dog Month 2
... Smoking cigarettes is not only the principle cause of ... the body,s immune responses to bacteria that commonly cause ... a mouse model. , "It is well established ... But our research also suggests that cigarette smoke substantially ...
... A group of Hollywood,s new moms, March of ... new public service announcement (PSA) to show their support ... that helps moms have full-term pregnancies and babies have ... )Volunteer moms include - Standing: Jenny Garth ...
... Mayer Laboratories, Inc., a marketer and distributor ... announced today that it has signed an agreement ... of the Today Sponge for the United States, ... Labs has marketed and distributed contraceptive and reproductive ...
... N.Y., April 6 Hands-on therapies are among the top-rated ... new survey by the Consumer ... Fifty-eight percent rated chiropractic/spinal manipulation as helping a lot. ... up. Consumers also rated their satisfaction with practitioners, telling ...
... of a drug from the adverse side effects , ... raising levels of "good" cholesterol and lowering levels of "bad" ... heart attack. However, patients often stop taking the drug due ... often includes an intense burning and itching sensation. A way ...
... Brief stress management sessions prior to and immediately after ... men undergoing a radical prostatectomy for early-stage prostate cancer, ... D. Anderson Cancer Center. , The study, in the ... , is the first to examine the benefits of ...
Cached Medicine News:Health News:Cigarette smoke may alter immune response in COPD exacerbations 2Health News:Cigarette smoke may alter immune response in COPD exacerbations 3Health News:Hollywood Moms Team Up For March For Babies 2Health News:Mayer Labs Acquires Today(R) Sponge Distribution Rights 2Health News:Consumer Reports Survey: Hands-On Therapies Among Top-Rated Treatments for Back Pain 2Health News:Consumer Reports Survey: Hands-On Therapies Among Top-Rated Treatments for Back Pain 3Health News:Consumer Reports Survey: Hands-On Therapies Among Top-Rated Treatments for Back Pain 4Health News:Consumer Reports Survey: Hands-On Therapies Among Top-Rated Treatments for Back Pain 5Health News:JCI online early table of contents: April 6, 2009 2Health News:JCI online early table of contents: April 6, 2009 3Health News:JCI online early table of contents: April 6, 2009 4Health News:JCI online early table of contents: April 6, 2009 5Health News:M. D. Anderson study finds pre-surgical stress management improves mood, quality of life 2Health News:M. D. Anderson study finds pre-surgical stress management improves mood, quality of life 3
... Designed to inform decision making, ... patient data on demand. Clinicians ... to lab results, medication profiles, ... profiles, and clinical notes such ...
... Thermo Labsystems was designed specifically to combine ... such as the new fast dial system ... help to define this as a new ... interchangeable handle plate offers a custom fit ...
Research Series 2100 Adjustable-volume Pipette, 0.1-2.5 l, single-channel with adjustable-volume setting...
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
Medicine Products: